Analysis of responses to high dose IL-2 (2 nM) confirmed the defect within the MTreg subset of ICL patients (p<0.01, Fig. 4E) and revealed an additional defect in the Memc subset (p<0.05, Fig. 3F). This evidence concerns the gene IL2 and idiopathic CD4 lymphocytopenia.